Loading provider…
Loading provider…
Medical Oncology Physician in Houston, TX
NPI: 1164886701Primary Employer
University of Texas MD Anderson Cancer Center
mdanderson.org
HQ Phone
Get MD Matthew's Phone Numberphone_androidMobile
Get MD Matthew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
2023
TX State Medical License
2022 - 2027
AZ State Medical License
2023 - 2026
GA State Medical License
2023 - 2026
OK State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
LA State Medical License
2023 - 2025
MS State Medical License
2023 - 2025
TN State Medical License
2023 - 2025
WA State Medical License
2023 - 2025
OH State Medical License
2016 - 2023
NE State Medical License
2019 - 2020

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Case Western Reserve University/University Hospitals Cleveland Medical Center
Residency • Internal Medicine
Until 2016
Georgetown University School Of Medicine
som.georgetown.edu
Medical School
Until 2016
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 76 | 127 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 43 | 43 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 31 | 42 |
| 4 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | 24 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 16 | 17 |
Preclinical discovery and development of abemaciclib used to treat breast cancer.
Authors: Tiffany Onger, Azadeh Nasrazadani, Matthew Wright, Megan Kruse
Journal: J Natl Cancer Inst
Immune checkpoint inhibition in early-stage triple-negative breast cancer.